RGNX
Price
$8.92
Change
+$0.05 (+0.56%)
Updated
Apr 24, 02:46 PM (EDT)
Capitalization
391.91M
6 days until earnings call
VYGR
Price
$3.49
Change
+$0.12 (+3.56%)
Updated
Apr 23 closing price
Capitalization
192.12M
19 days until earnings call
Ad is loading...

RGNX vs VYGR

Header iconRGNX vs VYGR Comparison
Open Charts RGNX vs VYGRBanner chart's image
REGENXBIO
Price$8.92
Change+$0.05 (+0.56%)
Volume$500
Capitalization391.91M
Voyager Therapeutics
Price$3.49
Change+$0.12 (+3.56%)
Volume$299.83K
Capitalization192.12M
RGNX vs VYGR Comparison Chart
Loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGNX vs. VYGR commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGNX is a Buy and VYGR is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (RGNX: $8.87 vs. VYGR: $3.48)
Brand notoriety: RGNX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGNX: 165% vs. VYGR: 82%
Market capitalization -- RGNX: $391.91M vs. VYGR: $192.12M
RGNX [@Biotechnology] is valued at $391.91M. VYGR’s [@Biotechnology] market capitalization is $192.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGNX’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • RGNX’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than RGNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGNX’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • RGNX’s TA Score: 4 bullish, 6 bearish.
  • VYGR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than RGNX.

Price Growth

RGNX (@Biotechnology) experienced а +43.99% price change this week, while VYGR (@Biotechnology) price change was +11.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

RGNX is expected to report earnings on Jul 30, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($392M) has a higher market cap than VYGR($192M). RGNX YTD gains are higher at: 14.748 vs. VYGR (-38.624). VYGR has higher annual earnings (EBITDA): -78.56M vs. RGNX (-198.23M). VYGR has more cash in the bank: 267M vs. RGNX (235M). VYGR has less debt than RGNX: VYGR (43.7M) vs RGNX (82M). RGNX (83.3M) and VYGR (80M) have equivalent revenues.
RGNXVYGRRGNX / VYGR
Capitalization392M192M204%
EBITDA-198.23M-78.56M252%
Gain YTD14.748-38.624-38%
P/E RatioN/A6.00-
Revenue83.3M80M104%
Total Cash235M267M88%
Total Debt82M43.7M188%
FUNDAMENTALS RATINGS
RGNX vs VYGR: Fundamental Ratings
RGNX
VYGR
OUTLOOK RATING
1..100
159
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9591
PRICE GROWTH RATING
1..100
7690
P/E GROWTH RATING
1..100
177
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (38) in the Biotechnology industry is somewhat better than the same rating for RGNX (76). This means that VYGR’s stock grew somewhat faster than RGNX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RGNX (100). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

VYGR's SMR Rating (91) in the Biotechnology industry is in the same range as RGNX (95). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

RGNX's Price Growth Rating (76) in the Biotechnology industry is in the same range as VYGR (90). This means that RGNX’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (7) in the Biotechnology industry is in the same range as RGNX (17). This means that VYGR’s stock grew similarly to RGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RGNXVYGR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
78%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CRMEX5.69N/A
N/A
CRM All Cap Value Inv
MPDRX8.46N/A
N/A
MassMutual Disciplined Gr R3
GCCSX28.29N/A
N/A
Gabelli Small Cap Growth C
MXVIX33.92N/A
N/A
Empower S&P 500® Index Investor
DHTYX21.45N/A
N/A
Diamond Hill Select Y

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with RCKT. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+13.43%
RCKT - RGNX
59%
Loosely correlated
+2.44%
DNLI - RGNX
54%
Loosely correlated
+1.85%
ARWR - RGNX
53%
Loosely correlated
+5.26%
NTLA - RGNX
53%
Loosely correlated
-2.65%
BEAM - RGNX
50%
Loosely correlated
+3.87%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+3.26%
RGNX - VYGR
50%
Loosely correlated
+13.43%
TRDA - VYGR
48%
Loosely correlated
N/A
XENE - VYGR
46%
Loosely correlated
+2.23%
RCKT - VYGR
46%
Loosely correlated
+2.44%
XNCR - VYGR
45%
Loosely correlated
+2.07%
More